Thioredoxin Systems AB
4Patents
4Active
4Granted
42Portfolio score
Filing activity: Mar 23, 2011 → May 18, 2020 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8592468B2 | Bacterial thioredoxin reductase inhibitors and methods for use thereof | Emerging Cross-Sectional Technologies | 7 | Active |
| US10058542B1 | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith | Emerging Cross-Sectional Technologies | 3 | Active |
| US11801262B2 | Antibiotic compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11013730B1 | Composition comprising selenazol or thiazalone derivatives and silver and method of treatment therewith | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.